About 4 million American adults have the chronic condition. Treatment may include a combination of painkillers, cognitive ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

The US Patent and Trademark Office (USPTO) has granted a patent to Vistagen’s non-opioid oral product candidate, AV-101 for ...

Compared to the control drugs tested (gabapentin and MK-801), AV-101 has similar robust anti ... Further preclinical research conducted by Dr. Yaksh comparing AV-101 to pregabalin in the Chung ...

Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...

(ABC 6 News) — The Food and Drug Administration has approved a first of its kind prescription pain medication that is non-opioid. The drug is called Journavx, and it is taken orally twice per day.

A new kind of pain medication has been approved for sale by the Food and Drug Administration. It is being touted as an alternative to opioids. It works differently, and it is not addictive.

The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx (suzetrigine) ...

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. For the first time in over two decades, the U.S. Food and Drug Administration (FDA) has ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, the first new class of pain medication in more than two decades. Developed by Vertex Pharmaceuticals, the drug-known generically as ...

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years. “Today’s approval is an important public health ...